As of 2025-09-16, the Relative Valuation of Oric Pharmaceuticals Inc (ORIC) is (18.44) USD. This relative valuation is based on P/E multiples. With the latest stock price at 10.71 USD, the upside of Oric Pharmaceuticals Inc based on Relative Valuation is -272.2%.
The range of the Relative Valuation is (18.06) - (18.79) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 12.8x - 13.4x | 13.1x |
| Forward P/E multiples | 12.8x - 13.3x | 13.0x |
| Fair Price | (18.06) - (18.79) | (18.44) |
| Upside | -268.6% - -275.4% | -272.2% |
| Date | P/E |
| 2025-09-08 | -7.61 |
| 2025-09-05 | -7.71 |
| 2025-09-04 | -7.63 |
| 2025-09-03 | -7.51 |
| 2025-09-02 | -7.36 |
| 2025-08-29 | -7.25 |
| 2025-08-28 | -7.11 |
| 2025-08-27 | -7.27 |
| 2025-08-26 | -6.98 |
| 2025-08-25 | -6.82 |
| 2025-08-22 | -6.90 |
| 2025-08-21 | -6.87 |
| 2025-08-20 | -6.74 |
| 2025-08-19 | -6.81 |
| 2025-08-18 | -7.02 |
| 2025-08-15 | -6.85 |
| 2025-08-14 | -7.04 |
| 2025-08-13 | -6.97 |
| 2025-08-12 | -6.75 |
| 2025-08-11 | -6.52 |
| 2025-08-08 | -6.55 |
| 2025-08-07 | -6.83 |
| 2025-08-06 | -7.00 |
| 2025-08-05 | -7.08 |
| 2025-08-04 | -6.91 |
| 2025-08-01 | -7.17 |
| 2025-07-31 | -7.07 |
| 2025-07-30 | -7.59 |
| 2025-07-29 | -7.83 |
| 2025-07-28 | -7.93 |
| 2025-07-25 | -8.11 |
| 2025-07-24 | -8.32 |
| 2025-07-23 | -8.37 |
| 2025-07-22 | -7.90 |
| 2025-07-21 | -7.84 |
| 2025-07-18 | -7.81 |
| 2025-07-17 | -7.90 |
| 2025-07-16 | -7.93 |
| 2025-07-15 | -7.78 |
| 2025-07-14 | -7.69 |
| 2025-07-11 | -7.87 |
| 2025-07-10 | -8.12 |
| 2025-07-09 | -7.73 |
| 2025-07-08 | -7.39 |
| 2025-07-07 | -7.55 |
| 2025-07-03 | -7.66 |
| 2025-07-02 | -7.55 |
| 2025-07-01 | -7.19 |
| 2025-06-30 | -7.20 |
| 2025-06-27 | -7.31 |